PL370832A1 - Azotowe związki tetrahydropirydylo-alkilo-heterocykliczne o aktywności TNF - Google Patents
Azotowe związki tetrahydropirydylo-alkilo-heterocykliczne o aktywności TNFInfo
- Publication number
- PL370832A1 PL370832A1 PL02370832A PL37083202A PL370832A1 PL 370832 A1 PL370832 A1 PL 370832A1 PL 02370832 A PL02370832 A PL 02370832A PL 37083202 A PL37083202 A PL 37083202A PL 370832 A1 PL370832 A1 PL 370832A1
- Authority
- PL
- Poland
- Prior art keywords
- alkyl
- tetrahydropyridyl
- heterocycles
- nitrogenous
- tnf activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0114897A FR2832405B1 (fr) | 2001-11-19 | 2001-11-19 | Tetrahydropyridyl-alkyl-heterocycles azotes, procede pour leur preparation et compositions pharmaceutiques les contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
PL370832A1 true PL370832A1 (pl) | 2005-05-30 |
PL208647B1 PL208647B1 (pl) | 2011-05-31 |
Family
ID=8869506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL370832A PL208647B1 (pl) | 2001-11-19 | 2002-11-18 | Tetrahydropirydylo-alkilo-benzodiazyny, sposób ich wytwarzania, środek farmaceutyczny, zastosowanie, lek oraz związki pośrednie |
Country Status (12)
Country | Link |
---|---|
US (1) | US7211578B2 (pl) |
EP (1) | EP1448550B1 (pl) |
JP (1) | JP4603794B2 (pl) |
AT (1) | ATE499359T1 (pl) |
AU (1) | AU2002356244B2 (pl) |
CA (1) | CA2464721C (pl) |
DE (1) | DE60239284D1 (pl) |
FR (1) | FR2832405B1 (pl) |
HU (1) | HUP0402229A3 (pl) |
MX (1) | MXPA04004760A (pl) |
PL (1) | PL208647B1 (pl) |
WO (1) | WO2003044010A1 (pl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200840566A (en) * | 2006-12-22 | 2008-10-16 | Esteve Labor Dr | Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4885572A (pl) * | 1972-02-17 | 1973-11-13 | ||
JPS49100089A (pl) * | 1973-01-30 | 1974-09-20 | ||
JPS49100090A (pl) * | 1973-01-30 | 1974-09-20 | ||
JPS5236B2 (pl) * | 1973-03-28 | 1977-01-05 | ||
JPS5046669A (pl) * | 1973-03-28 | 1975-04-25 | ||
DE19517851A1 (de) * | 1995-05-16 | 1996-11-21 | Hoechst Ag | Organometallverbindung |
FR2757160B1 (fr) * | 1996-12-13 | 1999-03-12 | Sanofi Sa | 1-phenylalkyl-1,2,3,6-tetrahydropyridines |
US6316466B1 (en) * | 1998-05-05 | 2001-11-13 | Syntex (U.S.A.) Llc | Pyrazole derivatives P-38 MAP kinase inhibitors |
DZ2796A1 (fr) * | 1998-05-21 | 2003-12-01 | Smithkline Beecham Corp | Composés à fonction bis-aminométhyl-carbonyle nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. |
HUP0204444A3 (en) * | 1999-10-22 | 2004-07-28 | Sanofi Aventis | Phenyl- and pyridyl-tetrahydro-pyridines, process for their preparation and pharmaceutical compositions containing them |
FR2803593B1 (fr) * | 2000-01-06 | 2002-02-15 | Sanofi Synthelabo | Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant |
MY132006A (en) * | 2000-05-26 | 2007-09-28 | Schering Corp | ADENOSINE A2a RECEPTOR ANTAGONISTS |
-
2001
- 2001-11-19 FR FR0114897A patent/FR2832405B1/fr not_active Expired - Fee Related
-
2002
- 2002-11-18 US US10/495,890 patent/US7211578B2/en not_active Expired - Fee Related
- 2002-11-18 EP EP02803433A patent/EP1448550B1/fr not_active Expired - Lifetime
- 2002-11-18 AU AU2002356244A patent/AU2002356244B2/en not_active Ceased
- 2002-11-18 CA CA2464721A patent/CA2464721C/en not_active Expired - Fee Related
- 2002-11-18 AT AT02803433T patent/ATE499359T1/de not_active IP Right Cessation
- 2002-11-18 WO PCT/FR2002/003929 patent/WO2003044010A1/fr active Application Filing
- 2002-11-18 JP JP2003545647A patent/JP4603794B2/ja not_active Expired - Fee Related
- 2002-11-18 MX MXPA04004760A patent/MXPA04004760A/es active IP Right Grant
- 2002-11-18 DE DE60239284T patent/DE60239284D1/de not_active Expired - Lifetime
- 2002-11-18 PL PL370832A patent/PL208647B1/pl not_active IP Right Cessation
- 2002-11-18 HU HU0402229A patent/HUP0402229A3/hu unknown
Also Published As
Publication number | Publication date |
---|---|
ATE499359T1 (de) | 2011-03-15 |
FR2832405B1 (fr) | 2004-12-10 |
WO2003044010A1 (fr) | 2003-05-30 |
DE60239284D1 (de) | 2011-04-07 |
JP4603794B2 (ja) | 2010-12-22 |
US7211578B2 (en) | 2007-05-01 |
AU2002356244B2 (en) | 2008-07-24 |
MXPA04004760A (es) | 2004-07-30 |
US20050004132A1 (en) | 2005-01-06 |
FR2832405A1 (fr) | 2003-05-23 |
HUP0402229A3 (en) | 2009-07-28 |
PL208647B1 (pl) | 2011-05-31 |
HUP0402229A2 (hu) | 2005-02-28 |
AU2002356244A1 (en) | 2003-06-10 |
EP1448550B1 (fr) | 2011-02-23 |
EP1448550A1 (fr) | 2004-08-25 |
JP2005509678A (ja) | 2005-04-14 |
CA2464721A1 (en) | 2003-05-30 |
CA2464721C (en) | 2011-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS196691A3 (en) | O-benzyloximeether and a fungicide containing said compound | |
IL114894A0 (en) | Endothelin antagonists | |
DK1382604T3 (da) | Quinolinderivater med en azolylgruppe og quinazolinderivater | |
GB9625045D0 (en) | Parasiticidal compounds | |
YU48714B (sh) | Derivati benzofurana, benzotiofena, indola i indolizina i postupak za njihovo dobijanje | |
EP0776894A4 (en) | OXAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND HERBICIDE | |
MD960282A (en) | Herbicidal heterocyclic-substituted pyridines | |
WO2002044153A8 (en) | 4-6-diphenyl pyridine derivatives as antiinflammatory agents | |
HK1083494A1 (en) | N-heteroarylnicotinamide derivatives | |
MY132009A (en) | Pharmaceutical compounds. | |
MXPA03004426A (es) | Proceso quimico y nuevos intermediarios. | |
GR3003118T3 (en) | Therapeutic agents | |
PL370832A1 (pl) | Azotowe związki tetrahydropirydylo-alkilo-heterocykliczne o aktywności TNF | |
MXPA03011032A (es) | Activadores de derivados de oxazol/tiazol del receptor hppar-alfa. | |
IL158641A0 (en) | Process for preparing a thiazole ppar-ligand and polymorphs thereof | |
MX9705649A (es) | Compuestos de fenilo substituidos como antagonistas de endotelinas. | |
BG106048A (en) | 6-[[(aryl and heteroaryl)oxy]methyl]naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof | |
DK0435235T3 (da) | Nye isoquinolinderivater og salte deraf | |
GR3032394T3 (en) | Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators | |
TW350843B (en) | 2-(4-pyrazolyloxy-pyrimidin-5-yl) acetic acid derivatives | |
EP1020426A4 (en) | AMINE DERIVATIVES AND THEIR PRODUCTION PROCESS | |
PL338944A1 (en) | Method of obtaining n-[5-(diphenylphosphinoylmethyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl]-n-methylmethanesulphonamide | |
DE69701770D1 (de) | Enolether und ihre Verwendung als Fungizide | |
WO2001034576A3 (en) | Use of pyrimidinone derivatives for controlling undesired microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Decisions on the lapse of the protection rights |
Effective date: 20111118 |